Regulation of pancreatic β-cell glucokinase: From basics to therapeutics

Diabetes

Volumn 51, Issue SUPPL. 3, 2002, Pages

  Matschinsky, Franz M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE; RECOMBINANT ENZYME;

ALLOSTERISM; ANIMAL CELL; AUTOSOMAL DOMINANT DISORDER; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; GENE MUTATION; GLUCOSE HOMEOSTASIS; INSULIN RELEASE; MATHEMATICAL MODEL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; WILD TYPE;

EID: 0036896635     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s394     Document Type: Conference Paper

References (53)

1. Bell GI, Cuesta-Munoz A, Matschinsky FM: Glucokinase. In Encyclopedia of Molecular Medicine. New York, John Wiley & Sons, 2002, p. 1437-1442
2. Iynedjian PB: Mammalian glucokinase and its gene. Biochem J 293:1-13, 1993
3. Magnuson MA: Glucokinase gene structure: Functional implications of molecular genetic studies. Diabetes 39:523-527, 1990
4. Matschinsky FM: Banting Lecture 1995: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45:223-241, 1996
5. Cardenas ML: "Glucokinase": Its regulation and role in liver metabolism. In Molecular Biology Intelligence Unit. Lands RG, Ed. Austin, TX, Springer, 1995, p. 210
6. Vanderkammen A, Van Schaftingen E: The mechanism by which rat liver glucokinase is inhibited by the regulatory protein. Euro J Biochem 191:483-489, 1990
7. Agius L, Peak M, Van Schaftingen E: The regulatory protein of glucokinase binds to the hepatocyte matrix but unlike glucokinase, does not translocate during substrate stimulation. Biochem J 309:711-713, 1995
8. Liang Y, Bonner-Weir S, Wu YJ, Berdanier CD, Berner DK, Efrat S, Matschinsky FM: In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents. J Clin Invest 93:2473-2481, 1994
9. Zawalich W, Dye ES, Pagliara AS, Rognstad R, Matschinsky FM: Starvation diabetes in the rat: Onset, recovery and specificity of reduced responsiveness of pancreatic β-cell. Endocrinology 104:1344-1351, 1979
10. Iynedjian P, Pilot P-R, Nouspikel T, Milburn L, Quaade C, Hughes S, Newgard CB: Differential expression and regulation of the glucokinase gene in liver and islets: Implications for control of glucose homeostasis. Proc Natl Acad Sci US A 86:7838-7842, 1989
11. Liang Y, Najafi H, Smith RM, Zimmerman EC, Magnuson MA, Tal M, Matschinsky FM: Concordant glucose induction of glucokinase, glucose usage, and glucose stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes 41:792-806, 1992
12. Ye Qui L, Nevin PW, Leahy JL: β-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia. Am J Physiol Endocrinol Metab 278:68-73, 2000
13. Bedoya FJ, Matschinsky FM, Shimizu T, O'Neil JJ, Appel MC: Differential regulation of glucokinase activity in pancreatic islets and liver of rat. J Biol Chem 261:10760-10764, 1986
14. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM, Berggren PO: Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β-cells. Mol Cell 7:559-570, 2001
15. Girard J, Ferre P, Foufelle F: Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr 17:325-352, 1997
16. Zawalich WS, Rognstad R, Pagliara AS, Matschinsky FM: A comparison of the utilization rates and hormone-releasing actions of glucose, mannose, and fructose in isolated pancreatic islets. J Biol Chem 252:8519-8523, 1977
17. Grimsby J, Coffey JW, Dovorozniak MT, Magram J, Li G, Matschinsky FM, Shiota C, Kaur S, Magnuson MA, Grippo JF: Characterization of glucokinase regulatory protein deficient mice. J Biol Chem 275:7826-7831, 2000
18. Davis EA, Cuesta-Munoz A, Raoul M, Buettger C, Sweet I, Moates M, Magnuson MA, Matschinsky FM: Mutants of glucokinase cause hypo- and hyperglycemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia 42:1175-1186, 1999
19. Liang Y, Kesavan P, Wang L, Niswender K, Tanizawa Y, Permutt MA, Magnuson MA, Matschinsky FM: Variable effects of MODY-associated glucokinase mutations on substrate interactions and stability of the enzyme. Biochem J 309:167-173, 1995
20. Kesavan P, Wang L, Davis E, Cuesta A, Sweet I, Niswender K, Magnuson MA, Matschinsky FM: Structural instability of mutant β-cell glucokinase: Implications for the molecular pathogenesis of maturity-onset diabetes of the young (type 2). Biochem J 322:57-63, 1997
21. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold HC: Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226-230, 1998
22. Njolstad PR, Sovic O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F, Undlien DE, Shiota C, Magnuson MA, Molven A, Matschinsky FM, Bell GI: Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588-1592, 2001
23. Christensen HBT, Jacobsen BB, Odili S, Buettger C, Cuesta-Munoz A, Hansen T, Brusgaard K, Magnuson MA, Shiota C, Matschinsky FM, Barbetti F: The second activating mutation (a456v): Implications for glucose homeostasis and diabetes therapy. Diabetes. 51:1240-1246, 2002
24. Miller SP, Anand GR, Karschnia EJ, Bell GI, La Porte DC, Lange AJ: Characterization of glucokinase mutants associated with maturity onset diabetes of the young type 2 (MODY-2): Different glucokinase defects lead to a common phenotype. Diabetes 48:1645-1651, 1999
25. Froguel P, Zouali H, Vionnet N, Velho G, Vdaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt A, Beckmann JS, Bell GI, Cohen D: Familial hyperglycemia due to mutations in glucokinase. N Engl J Med 328:697-702, 1993
26. Matschinsky FM, Davis E, Cuesta-Munoz A, Buettger C, Sweet I, Moates M, Magnuson MA: The glucokinase system and the regulation of blood sugar. In Molecular Pathogenesis of MODYs. Frontiers in Diabetes. Vol. 15. Matschinsky FM, Magnuson MA, Eds. Basel, Karger, 2000, p. 99-108
27. Massa O, Meschi F, Cuesta-Munoz A, Caumo A, Cerutti F, Toni S, Cherubini V, Guazzarotti L, Sulli N, Matschinsky FM, Lorini R, Iafusco D, Barbetti F: High prevalence of glucokinase mutations in Italian children with MODY: Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetologia 44:898-905, 2001
28. Cuesta-Munoz A, Buettger C, Davis E, Shiota C, Magnuson MA, Grippo JF, Grimsby J, Matschinsky FM: Novel pharmacological glucokinase activators partly or fully reverse the catalytic defects of inactivating glucokinase missense mutants that cause MODY-2 (Abstract). Diabetes 50 (Suppl. 2):A109, 2001
29. Grimsby J, Sarabu R, Bizzaro FT, Coffey JW, Chu CA, Corbett WL, Dvorozniak MT, Guertin K, Haynes N-E, Hilliard DW, Kester RF, Matschinsky FM, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Grippo J: Allosteric activation of islet and hepatic glucokinase: A potential new approach to diabetes therapy (Abstract). Diabetes 50 (Suppl. 2):A115, 2001
30. Doliba N, Vatamaniuk M, Najafi H, Boettger C, Collins H, Grippo J, Grimsby J, Matschinsky FM: Novel pharmacological glucokinase activators enhance glucose metabolism, respiration and insulin release in isolated pancreatic islets demonstrating a unique therapeutic potential (Abstract). Diabetes 50 (Suppl. 2):A359, 2001
31. Liang Y, Najafi H, Matschinsky FM: Glucose regulates glucokinase activity in cultured islets from rat pancreas. J Biol Chem 265:16863-16866, 1990
32. Leahy JL: β-cell dysfunction with chronic hyperglycemia: The "over-worked" β-cell. Diabetes Reviews 4:298-319, 1996
33. Leahy JL, Bumbalo LM, Chen C: Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats. Diabetologia 36:1238-1244, 1993
34. Sorenson RL, Brelje TC: Adaptation of islets of Langerhans to pregnancy: Beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301-307, 1997
35. Fernandez-Mejia C, Vega-Allende J, Rojas-Ochoa A, Rodriguez-Dorantes M, Romero-Navarro G, Matschinsky FM, Wang J, German MS: Cyclic adenosine 3′,5′-monophosphate increases pancreatic glucokinase activity and gene expression. Endocrinology 142:1448-1452, 2001
36. Romero-Navarro G, Cabrera-Valladares G, German MS, Matschinsky FM, Velazauez A, Wang J, Fernandez-Mejia C: Biotin regulation of pancreatic glucokinase and insulin in primary cultured rat islets and in biotin-deficient rats. Endocrinology 140:4595-4600, 1999
37. Cabrera-Valladares G, German MS, Matschinsky FM, Wang J, Fernandez-Mejia C: Effect of retinoic acid on glucokinase activity and gene expression and on insulin secretion in primary cultures of pancreatic islets. Endocrinology 140:3091-3096, 1999
38. Rothenberg PL, Willison LD, Simon J, Wolf BA: Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting β-cells. Diabetes 44: 802-809, 1995
39. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR: Tissue-specific knockout of the insulin receptor in pancreatic β-cells creates an insulin secretory defect similar to that of type 2 diabetes. Cell 96:329-339, 1999
40. White M: IRS-2 is a common element in peripheral insulin signaling and β-cell function. In Molecular Pathogenesis of MODYs. Frontiers in Diabetes. Vol. 15. Matschinsky FM, Magnuson MA, Eds. Basel, Karger, 2000, p. 209-218
41. 2+ stores in insulin-stimulated insulin secretion in β-cells. J Biol Chem 275:22331-22338, 2000
42. Leibiger IB, Leibiger B, Moede T, Berggren PO: Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1:933-938, 1998
43. ATP channel-independent regulation of insulin secretion. J Biol Chem 275:9270-9277, 2000
44. ATP channel. Proc Natl Acad Sci U S A 94:11969-11973, 1997
45. Toyoda Y, Yoshie S, Shironoguchi H, Miwa I: Glucokinase is concentrated in insulin-secretory granules of pancreatic β-cells. Histochem Cell Biol 112:35-40, 1999
46. Stubbs M, Aiston S, Agius L: Subcellular localization, mobility, and kinetic activity of glucokinase in glucose-responsive insulin-secreting cells. Diabetes 49:2048-2055, 2000
47. Noma Y, Bonner-Weir S, Latimer JB, Davalli AM, Weir GC: Translocation of glucokinase in pancreatic β-cells during acute and chronic hyperglycemia. Endocrinology 137:1485-1491, 1996
48. Shah N, Zelent D, Najafi H, Burke C, Raper S, Cuesta-Munoz A, Matschinsky FM, Jarett L: Electron microscopic demonstration of glucokinase in insulin granules of rat pancreatic beta-cells (Abstract). Diabetes 50 (Suppl. 2):A353, 2001
49. st Century, Engineering a Pathway to Greater Understanding. National Institute of Diabetes and Digestive and Kidney Diseases, 2001, p. 16
50. Alvarez E, Roncero I, Chowen JA, Vazquez P, Blazquez E: Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. J Neurochem 80:45-53, 2002
51. Burch PT, Berner DK, Najafi H, Meglasson MD, Matschinsky FM: Regulatory role of fructose 2,6-disphosphate in pancreatic islet glucose metabolism remains unsettled. Diabetes 34:1014-1018, 1985
52. Baltrusch S, Lenzen S, Okar DA, Lange AJ, Tiedge M: Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library: Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner. J Biol Chem 276:43915-43923, 2001
53. Mahalingam B, Cuesta-Munoz AL, Davis E, Matschinsky FM, Harrison R, Weber I: Structural model of human glucokinase in complex with glucose and ATP: Implications for the mutants that cause hypo- and hyperglycemia. Diabetes 48:1698-1705, 1999